Department of Global Health, University of Washington, Seattle, Washington, USA
Department of Medicine, University of Washington, Seattle, Washington, USA.
Clin Microbiol Rev. 2019 May 15;32(3). doi: 10.1128/CMR.00097-18. Print 2019 Jun 19.
The global public health community has set ambitious treatment targets to end the HIV/AIDS pandemic. With the notable absence of a cure, the goal of HIV treatment is to achieve sustained suppression of an HIV viral load, which allows for immunological recovery and reduces the risk of onward HIV transmission. Monitoring HIV viral load in people living with HIV is therefore central to maintaining effective individual antiretroviral therapy as well as monitoring progress toward achieving population targets for viral suppression. The capacity for laboratory-based HIV viral load testing has increased rapidly in low- and middle-income countries, but implementation of universal viral load monitoring is still hindered by several barriers and delays. New devices for point-of-care HIV viral load testing may be used near patients to improve HIV management by reducing the turnaround time for clinical test results. The implementation of near-patient testing using these new and emerging technologies may be an essential tool for ensuring a sustainable response that will ultimately enable an end to the HIV/AIDS pandemic. In this report, we review the current and emerging technology, the evidence for decentralized viral load monitoring by non-laboratory health care workers, and the additional considerations for expanding point-of-care HIV viral load testing.
全球公共卫生界制定了雄心勃勃的治疗目标,以期终结艾滋病大流行。由于缺乏根治方法,艾滋病毒治疗的目标是实现艾滋病毒载量的持续抑制,从而实现免疫恢复并降低艾滋病毒传播的风险。因此,监测艾滋病毒感染者的艾滋病毒载量对于维持有效的个体抗逆转录病毒治疗以及监测实现艾滋病毒抑制人群目标的进展情况至关重要。在中低收入国家,基于实验室的艾滋病毒载量检测能力迅速提高,但由于存在若干障碍和延迟,普遍开展艾滋病毒载量监测的工作仍受到阻碍。新型即时护理点艾滋病毒载量检测设备可在患者附近使用,通过减少临床检测结果的周转时间,改善艾滋病毒管理。使用这些新出现技术实施近患者检测,可能是确保可持续应对的重要工具,最终将实现终结艾滋病大流行的目标。在本报告中,我们回顾了现有和新兴技术、非实验室卫生保健工作者进行分散式病毒载量监测的证据,以及扩大即时护理点艾滋病毒载量检测的额外考虑因素。